Company profile: Multisorb
1.1 - Company Overview
Company description
- Provider of active packaging technology and sorbent solutions that protect products from moisture, oxygen, and volatiles, including desiccants, oxygen absorbers, and volatile/odor control. Offers SimulSorb and SimulOx simulation programs to predict pharmaceutical stability, APA series dispensing equipment to streamline production, and R&D services for tailored active packaging systems, testing, and evaluation.
Products and services
- Desiccants: Multisorb fabricates moisture-absorbing components in packet-and-canister format that protect products from moisture damage, safeguarding packaged items using Active Packaging Technology
- Oxygen Absorbers: Multisorb produces in-package oxygen-scavenging products that absorb oxygen to prevent degradation and extend shelf life within packaging
- Volatile & Odor Control: Multisorb engineers active-packaging sorbents that control volatiles and odors impacting product appeal and performance, maintaining packaging quality
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Multisorb
BioMedion
HQ: Germany
Website
- Description: Provider of compliance management software and services for the highly regulated life science industry, medicines agencies, and national competent authorities. Offers GxP quality, compliance, and archiving solutions, including neuronOS, IMAGE+, WATCH+, regulatory operations services, raw data archiving, and subject-matter expertise, computer system validation, and training management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioMedion company profile →
Prolaio
HQ: United States
Website
- Description: Provider of prescriptive analytics-driven HealthTech solutions for continuous cardiac monitoring and risk assessment, including post-discharge heart failure and hypertrophic cardiomyopathy systems, AI-powered predictive analytics for care teams, remote monitoring for clinical studies, and a patient app for data collection, guidance, and reporting to support early intervention and reduce readmissions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prolaio company profile →
Eximia Research
HQ: United States
Website
- Description: Provider of multi-therapeutic clinical research site network services for biotech companies, conducting Phase I–IV clinical trials across therapeutic and diagnostic indications. Offers patient recruitment and engagement (including underrepresented populations), feasibility studies with investigator feedback, rapid site start-up and feasibility, regulatory and start-up support (contract and budget management), and quality assurance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eximia Research company profile →
Health Decisions
HQ: United States
Website
- Description: Provider of full-service contract research organization services specializing in clinical studies of therapeutics for women’s health and diagnostics across all therapeutic areas; focused on women’s health for over 28 years with more than 100 trials in women-only indications such as contraception, serving forward-looking biopharma and medical device companies and supporting modernization of clinical development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Health Decisions company profile →
Avid Bioservices
HQ: United States
Website
- Description: Provider of end-to-end biologics services, including mammalian protein process development, drug substance development, CGMP manufacturing from early stages to commercial scale, and analytical services; also specializes in viral vector design, optimization, and scalable production for gene therapy and vaccine applications. Expansion doubles capacity to service a $40m backlog and support owner Peregrine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avid Bioservices company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Multisorb
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Multisorb
2.2 - Growth funds investing in similar companies to Multisorb
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Multisorb
4.2 - Public trading comparable groups for Multisorb
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →